| 6.81 Data as of 3:24pm ET |  -0.27 / -3.81%Today’s Change | 3.30 Today|||52-Week Range 10.86 | +89.69% Year-to-Date |
| Previous close | 7.08 |
| Today’s open | 7.10 |
| Day’s range | 6.71 - 7.10 |
| Volume | 246,740 |
| Average volume (3 months) | 394,236 |
| Market cap | $295.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +52.11% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +166.67% |
| P/E ratio | NM |
| Price/Sales | 2,440.02 |
| Price/Book | 10.95 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACHNAchillion Pharmaceut... | +0.01 | +0.15% |
| SVASinovac Biotech Ltd | -0.08 | -1.40% |
| ONTXOnconova Therapeutic... | -1.14 | -7.03% |
| ZGNXZogenix Inc | -0.20 | -6.15% |
| Next reporting date | February 26, 2014 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $50.0K |
| Annual profit (last year) | -$11.6M |
| Net profit margin | -23,186.09% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Operating Officer Joshua R. Disbrow |
Corporate headquarters Greenwood Village, Colorado |
.
